XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.3
Net Income Per Share of Common Stock
 9 Months Ended
Sep. 30, 2025
Net Income Per Share of Common Stock [Abstract]  
Net Income Per Share of Common Stock
Note 8 – Net Income Per Share of Common Stock

Basic net income per share is based on the weighted average number of shares of common stock outstanding during the period, which does not include unvested restricted common stock subject to forfeiture of 1,751 shares for the period ended September 30, 2025, compared to 1,646 shares for the period ended September 30, 2024. Diluted net income per share reflects: a) the potential dilution assuming shares of common stock were issued upon the exercise of outstanding in-the-money options and the assumed proceeds, which are deemed to be the proceeds from the exercise plus compensation cost not yet recognized attributable to future services using the treasury method, were used to purchase shares of the Company’s common stock at the average market price during the period, b) the vesting of granted non-vested restricted stock awards for which the assumed proceeds upon vesting are deemed to be the amount of compensation cost not yet recognized attributable to future services using the treasury stock method, to the extent dilutive, and c) issued performance-based awards to the extent that the underlying performance conditions (i) have been satisfied as of the end of the reporting period or (ii) would be considered satisfied if the end of the reporting period were the end of the related contingency period and the result would be dilutive.

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Net income attributable to Steven Madden, Ltd.$20,528 $55,278 $21,474 $134,589 
Basic net income per share$0.29 $0.78 $0.30 $1.88 
Diluted net income per share$0.29 $0.77 $0.30 $1.87 
Weighted average common shares outstanding:
Basic70,90670,80670,85071,516 
Effect of dilutive securities:
Stock awards and options to purchase shares of common stock251763172619
Diluted71,15771,56971,02272,135
For the three and nine months ended September 30, 2025, options to purchase approximately 12 and 4 shares of common stock, in each period, have been excluded from the calculation of diluted net income per share as the result would have been anti-dilutive. For the three and nine months ended September 30, 2024, options to purchase approximately 32 and 26 shares of common stock have been excluded from the calculation of diluted net income per share as the result would have been anti-dilutive.
For the three and nine months ended September 30, 2025, 213 and 265 restricted shares were excluded from the calculation of diluted net income per share, compared to approximately zero and five shares that were excluded from the calculation of diluted net income per share for the three and nine months ended September 30, 2024, as the result would have been anti-dilutive. The Company had certain contingently issuable performance awards outstanding that did not meet the performance conditions as of September 30, 2025 and 2024 and, therefore, were excluded from the calculation of diluted net
income per common share for the three and nine months ended September 30, 2025 and 2024. The number of potentially dilutive shares that could be issued upon vesting for these performance-based awards was immaterial as of both September 30, 2025 and 2024. These amounts were also excluded from the computation of weighted average potentially dilutive securities.